Clarithromycin

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Biaxin (AbbVie); Biaxin HP; Clacine; Clarith; Klacid; Klaricid; Macladin; Veclam
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Antibiotic, macrolide, CYP3A4 inhibitor
  • HALF-LIFE: 5–7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abiraterone, Alprazolam, Aprepitant, Astemizole, Atazanavir, Atorvastatin, Avanafil, Benzodiazepines, Betrixaban, Boceprevir, Brigatinib, Cabazitaxel, Cabozantinib, Calcifediol, Carbamazepine, Chlordiazepoxide, Cilostazol, Clonazepam, Clorazepate, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Colchicine, Conivaptan, Copanlisib, Crizotinib, Cyclosporine, Dabigatran, Darunavir, Dasatinib, Deflazacort, Delavirdine, Diazepam, Digoxin, Dihydroergotamine, Disopyramide, Dronedarone, Efavirenz, Eletriptan, Eluxadoline, Ergot alkaloids, Estradiol, Etravirine, Everolimus, Fesoterodine, Flibanserin, Fluoxetine, Flurazepam, Fluticasone Propionate, Fluvastatin, HMG-CoA reductase inhibitors, Ibrutinib, Imatinib, Indinavir, Itraconazole, Ixabepilone, Lapatinib, Lomitapide, Lopinavir, Lorazepam, Lovastatin, Maraviroc, Methylergonovine, Methylprednisolone, Methysergide, Midazolam, Midostaurin, Mifepristone, Naldemedine, Neratinib, Nevirapine, Nilotinib, Olaparib, Omeprazole, Oxazepam, Oxtriphylline, Paclitaxel, Palbociclib, Paroxetine Hydrochloride, Pazopanib, Pimavanserin, Pimozide, Ponatinib, Pravastatin, Prednisone, Quazepam, Ranolazine, Regorafenib, Repaglinide, Ribociclib, Rilpivirine, Rimonabant, Rivaroxaban, Romidepsin, Ruxolitinib, Sertraline, Sildenafil, Silodosin, Simeprevir, Simvastatin, Solifenacin, Sunitinib, Tadalafil, Temazepam, Temsirolimus, Tezacaftor/Ivacaftor, Ticagrelor, Tipranavir, Tolvaptan, Trabectedin, Triazolam, Ulipristal, Valbenazine, Vandetanib, Vemurafenib, Venetoclax, Vorapaxar, Warfarin, Zidovudine

PREGNANCY CATEGORY: C

Our database has 89 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
RENAL
HEMATOLOGIC
OTIC
OCULAR
LOCAL
OTHER


Page last updated 03/06/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric